Across species structural and functional hemispheric asymmetry is a fundamental feature of the brain. Environmental and genetic factors determine this asymmetry during brain development and modulate its interaction with brain disorders. The e4 allele of the apolipoprotein E gene (APOE-4) is a risk factor for Alzheimer's disease, associated with regionally specific effects on brain morphology and function during the life span. Furthermore, entorhinal and hippocampal hemispheric asymmetry could be modified by pathology during Alzheimer's disease development. Using high-resolution magnetic resonance imaging and a cortical unfolding technique we investigated whether carrying the APOE-4 allele influences hemispheric asymmetry in the entorhinal cortex and the hippocampus among patients with Alzheimer's disease as well as in middle-aged and older cognitively healthy individuals. APOE-4 carriers showed a thinner entorhinal cortex in the left hemisphere when compared with the right hemisphere across all participants. Non-carriers of the allele showed this asymmetry only in the patient group. Cortical thickness in the hippocampus did not vary between hemispheres among APOE-4 allele carriers and noncarriers. The APOE-4 allele modulates hemispheric asymmetry in entorhinal cortical thickness. Among Alzheimer's disease patients, this asymmetry might be less dependent on the APOE genotype and a more general marker of incipient disease pathology.
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Introduction
Neuropathological hallmarks of Alzheimer's disease, beta amyloid plaques and neurofibrillary tangles, can be found in the brain decades before the onset of clinical symptoms (Braak and Braak, 1995) . In vivo detection of pathological changes that are closely associated with future cognitive deterioration could be critical for targeting novel therapies to those persons most likely to benefit from intervention. The spatial distribution of intraneuronal tangle pathology, rather than the pattern of extracellular amyloid deposition, is associated with neuronal loss and cognitive dysfunction (Gomez-Isla et al., 1997; Petersen et al., 2006) . In fact, these neurofibrillary tangles first occur in the transentorhinal region before spreading to the hippocampus and other neighboring cortices (Braak and Braak, 1995) . Multiple imaging metrics now exist for the identification of these neuropathological markers both before the onset, and during the progression of Alzheimer's disease. Modern methods include positron emission tomography (PET), using radioactive ligands that bind to plaques and tangles in the brain (Protas et al., 2010) , magnetic resonance imaging (MRI) of brain structure (Donix et al., 2010a) , function (Xu et al., 2009) 
